Trademark: 97374492
Word
NIYAD
Status
Pending
Status Code
730
Status Date
Thursday, May 16, 2024
Serial Number
97374492
Mark Type
4
Filing Date
Thursday, April 21, 2022
Published for Opposition
Tuesday, October 24, 2023

Trademark Owner History
TALPHERA, INC. - 1st New Owner After Publication
AcelRx Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceutical compounds in the nature of anti-coagulants and associated delivery devices, namely sealed vials containing the anti-coagulants that are designed for access via syringes and needles, all for use in the treatment of renal disease and disorders

Trademark Events
Apr 25, 2022
New Application Entered
Apr 27, 2022
New Application Office Supplied Data Entered
Dec 15, 2022
Assigned To Examiner
Dec 22, 2022
Non-Final Action Written
Dec 22, 2022
Non-Final Action E-Mailed
Dec 22, 2022
Notification Of Non-Final Action E-Mailed
Mar 21, 2023
Application Extension To Response Period - Received
Mar 21, 2023
Application Extension Granted/Receipt Provided
Jun 20, 2023
Teas Response To Office Action Received
Jun 20, 2023
Correspondence Received In Law Office
Jun 21, 2023
Teas/Email Correspondence Entered
Sep 20, 2023
Approved For Pub - Principal Register
Oct 4, 2023
Notification Of Notice Of Publication E-Mailed
Oct 24, 2023
Published For Opposition
Oct 24, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 24, 2024
Automatic Update Of Assignment Of Ownership
May 16, 2024
Sou Extension 1 Filed
May 16, 2024
Sou Extension 1 Granted
May 16, 2024
Sou Teas Extension Received
Sep 5, 2024
Teas Change Of Correspondence Received
Sep 5, 2024
Teas Change Of Owner Address Received
Sep 5, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 5, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 5, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 5, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
May 17, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24